Implementing the best treatment strategies is important when treating a patient with major depressive disorder (MDD), especially if first-line treatment fails. This article summarizes a presentation on...
A joint clinical practice guideline on the management of major depressive disorder was released earlier this year, which included 36 recommendations on screening, monitoring, and treating this condition. ...
A joint clinical practice guideline on the management of major depressive disorder was released earlier this year, which included 36 recommendations on screening, monitoring, and treating this condition. ...
Researchers examined how the cut-values of hypomania checklist-32, a common screening tool for differentiating between bipolar disorder and major depressive disorder, may be influenced by patient...
Researchers examined the relationship between the use of statins and markers of depression vulnerability to better understand the antidepressant potential of these medications.
To resolve uncertainty about the risk-benefit ratio of electroconvulsive therapy (ECT) on suicide risk, researchers examined the impact of ECT on individuals with depression.
In a recent study, researchers examined the long-term safety and effectiveness of the use of psilocybin-assisted treatment for individuals with major depressive disorder.
The US Food and Drug Administration has approved a shortened version of existing brain stimulation protocol for treatment-resistant major depressive disorder.
Individuals who are in remission or recovery from major depressive disorder are commonly kept on antidepressants to prevent relapse. Now, the authors of a recent study are proposing preventive cognitive...
